Tag Archives: Priority

Sanofi's dengue shot Dengvaxia wins FDA priority review despite controversial past

Sanofi has weathered controversy with its world-first dengue vaccine, Dengvaxia, but the company is pressing ahead, and on Tuesday said the FDA had not only accepted its application for approval, but also granted a priority review.  The FDA is set to decide on Sanofi’s vaccine by May 1, 2019. In granting the priority review, the FDA determined… Read More »

Pre-Existing Conditions: A Trans-Party, National Health Priority

Pre-existing conditions impact Americans north, south, east and west, the Kaiser Family Foundation maps. But those maladies aren’t evenly distributed across the U.S.: the highest incidences of people with pre-existing conditions are generally dotted in the eastern half of the U.S., in diverse metropolitan areas. This study looks at non-elderly adults, people between 18 and… Read More »